| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281842 | Clinical Gastroenterology and Hepatology | 2015 | 118 Pages |
Abstract
On the basis of a systematic review, NSAIDs are appropriate for use in prevention of PEP, especially for high-risk cases. Additional research is necessary to clarify the role of other pharmacologic agents. These findings could inform future research and guide clinical decision-making and policy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Nisa M. Kubiliun, Megan A. Adams, Venkata S. Akshintala, Marisa L. Conte, Gregory A. Cote, Peter B. Cotton, Jean-Marc Dumonceau, Grace H. Elta, Evan L. Fogel, Martin L. Freeman, Glen A. Lehman, Mariam Naveed, Joseph Romagnuolo, James M. Scheiman,